Medtech Insight is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Xience V making strides

This article was originally published in The Gray Sheet

Executive Summary

Guidant's everolimus-eluting stent has received a CE mark and will launch in the European Union by June , the company announced Jan. 30. Built on the firm's Multi-Link Vision stenting platform, the Xience V system is being evaluated in the SPIRIT III trial in the U.S. and Japan, with more than 70% of U.S. enrollment complete, the company says...
Advertisement

Related Content

Advertisement
UsernamePublicRestriction

Register

MT023196

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel